RAGE: A new frontier in chronic airways disease

British Journal of Pharmacology

Volumn 167, Issue 6, 2012, Pages 1161-1176

  Sukkar, Maria B ^a   Ullah, Md Ashik ^b   Gan, Wan Jun ^c   Wark, Peter A B ^d,e   Chung, Kian Fan ^f   Hughes, J Margaret ^g   Armour, Carol L ^b   Phipps, Simon ^c  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e JOHN HUNTER HOSPITAL   (Australia)

^f NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

asthma; chronic obstructive pulmonary disease (COPD); damage associated molecular patterns; high mobility group box 1 (HMGB1); neutrophilic airway inflammation; receptor for advanced glycation end products (RAGE); serum amyloid A (SAA); soluble RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CIGARETTE SMOKE; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; DISEASE EXACERBATION; DISEASE MODEL; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; HELPER CELL; HUMAN; INFLAMMATION; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; LYMPHOCYTE DIFFERENTIATION; MOLECULAR RECOGNITION; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; POLARIZATION; POLLUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ASTHMA; HUMANS; LIGANDS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, IMMUNOLOGIC;

EID: 84867772903     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01984.x     Document Type: Review

References (164)

1. Anderson GP, (2008). Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372: 1107-1119.
2. Ather JL, Ckless K, Martin R, Foley KL, Suratt BT, Boyson JE, et al,. (2011). Serum amyloid a activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J Immunol 187: 64-73.
3. Balasubbu S, Sundaresan P, Rajendran A, Ramasamy K, Govindarajan G, Perumalsamy N, et al,. (2010). Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy. BMC Med Genet 11: 158.
4. Barnes PJ, (2008a). Future treatments for chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc 5: 857-864.
5. Barnes PJ, (2008b). Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8: 183-192.
6. Basta G, Sironi AM, Lazzerini G, Del Turco S, Buzzigoli E, Casolaro A, et al,. (2006). Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. J Clin Endocrinol Metab 91: 4628-4634.
7. Belvisi MG, Mitchell JA, (2009). Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease. Br J Pharmacol 158: 994-1003.
8. Bezerra FS, Valença SS, Pires KMP, Lanzetti M, Pimenta WA, Schmidt AC, et al,. (2011). Long-term exposure to cigarette smoke impairs lung function and increases HMGB-1 expression in mice. Respir Physiol Neurobiol 177: 120-126.
9. Bianchi R, Kastrisianaki E, Giambanco I, Donato R, (2011). S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J Biol Chem 286: 7214-7226.
10. Bozinovski S, Hutchinson A, Thompson M, MacGregor L, Black J, Giannakis E, et al,. (2008). Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 269-278.
11. Bozinovski S, Uddin M, Vlahos R, Thompson M, McQualter JL, Merritt A-S, et al,. (2012). Serum amyloid A opposes lipoxin A4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 109: 935-940.
12. Brusselle GG, Joos GF, Bracke KR, (2011). New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378: 1015-1026.
13. Buckley S, Ehrhardt C, (2010). The receptor for advanced glycation end products (RAGE) and the lung. J Biomed Biotechnol 2010: Article ID 917108.
14. Buttari B, Profumo E, Capozzi A, Facchiano F, Saso L, Sorice M, et al,. (2011). Advanced glycation end products of human β2 glycoprotein I modulate the maturation and function of DCs. Blood 117: 6152-6161.
15. Büyüköztürk S, Gelincik AA, Genç S, Koçak H, Oneriyidogan Y, Erden S, et al,. (2004). Acute phase reactants in allergic airway disease. Tohoku J Exp Med 204: 209-213.
16. Cai H, Song C, Endoh I, Goyette J, Jessup W, Freedman SB, et al,. (2007). Serum amyloid a induces monocyte tissue factor. J Immunol 178: 1852-1860.
17. Campana L, Bosurgi L, Bianchi ME, Manfredi AA, Rovere-Querini P, (2009). Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J Leukoc Biol 86: 609-615.
18. Castaldi PJ, Cho MH, Litonjua AA, Bakke P, Gulsvik A, Lomas DA, et al,. (2011). The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am J Respir Cell Mol Biol 45: 1147-1153.
19. Castiglioni A, Canti V, Rovere-Querini P, Manfredi A, (2011). High-mobility group box 1 (HMGB1) as a master regulator of innate immunity. Cell Tissue Res 343: 189-199.
20. Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, et al,. (1997). Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA 94: 13915-13920.
21. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, et al,. (2003). The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198: 1507-1515.
22. Chen ES, Song Z, Willett MH, Heine S, Yung RC, Liu MC, et al,. (2010a). Serum amyloid a regulates granulomatous inflammation in sarcoidosis through toll-like receptor-2. Am J Respir Crit Care Med 181: 360-373.
23. Chen GY, Nuñez G, (2010b). Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10: 826-837.
24. Chen Y, Akirav EM, Chen W, Henegariu O, Moser B, Desai D, et al,. (2008). RAGE ligation affects T cell activation and controls T cell differentiation. J Immunol 181: 4272-4278.
25. Christaki E, Opal SM, Keith JCJ, Kessimian N, Palardy JE, Parejo NA, et al,. (2011). A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia. Shock 35: 492-498.
26. Daborg J, von Otter M, Sjölander A, Nilsson S, Minthon L, Gustafson D, et al,. (2010). Association of the RAGE G82S polymorphism with Alzheimer's disease. J Neural Transm 117: 861-867.
27. Dahlin K, Mager EM, Allen L, Tigue Z, Goodglick L, Wadehra M, et al,. (2004). Identification of genes differentially expressed in rat alveolar type I cells. Am J Respir Cell Mol Biol 31: 309-316.
28. Dattilo BM, Fritz G, Leclerc E, Vander Kooi CW, Heizmann CW, Chazin WJ, (2007). The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry 46: 6957-6970.
29. Demling N, Ehrhardt C, Kasper M, Laue M, Knels L, Rieber E, (2006). Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells. Cell Tissue Res 323: 475-488.
30. Dobbs LG, Johnson MD, Vanderbilt J, Allen L, Gonzalez R, (2010). The great big alveolar TI cell: evolving concepts and paradigms. Cell Physiol Biochem 25: 55-62.
31. Doz E, Noulin N, Boichot E, Guenon I, Fick L, Le Bert M, et al,. (2008). Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol 180: 1169-1178.
32. Dumitriu IE, Baruah P, Bianchi ME, Manfredi AA, Rovere-Querini P, (2005a). Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur J Immunol 35: 2184-2190.
33. Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP, et al,. (2005b). Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 174: 7506-7515.
34. Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA, Rovere-Querini P, (2007). The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol 81: 84-91.
35. Fehrenbach H, Kasper M, Tschernig T, Shearman MS, Schuh D, Müller M, (1998). Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung. Cell Mol Biol (Noisy-le-grand) 44: 1147-1157.
36. Ferhani N, Letuve S, Kozhich A, Thibaudeau O, Grandsaigne M, Maret M, et al,. (2010). Expression of high-mobility group box 1 and of receptor for advanced glycation end products in COPD. Am J Respir Crit Care Med 181: 917-927.
37. Friggeri A, Banerjee S, Biswas S, de Freitas A, Liu G, Bierhaus A, et al,. (2011). Participation of the receptor for advanced glycation end products in efferocytosis. J Immunol 186: 6191-6198.
38. Fritz G, (2011). RAGE: a single receptor fits multiple ligands. Trends Biochem Sci 36: 625-632.
39. Frommhold D, Kamphues A, Hepper I, Pruenster M, Lukic IK, Socher I, et al,. (2010). RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo. Blood 116: 841-849.
40. Gaens KHJ, Ferreira I, van der Kallen CJH, van Greevenbroek MMJ, Blaak EE, Feskens EJM, et al,. (2009). Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. J Clin Endocrinol Metab 94: 5174-5180.
41. Gao J, Shao Y, Lai W, Ren H, Xu D, (2010). Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population. J Hum Genet 55: 668-675.
42. Garantziotis S, Li Z, Potts EN, Kimata K, Zhuo L, Morgan DL, et al,. (2009a). Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice. J Biol Chem 284: 11309-11317.
43. Garantziotis S, Li Z, Potts EN, Lindsey JY, Stober VP, Polosukhin VV, et al,. (2009b). TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation. Am J Respir Crit Care Med 181: 666-675.
44. Ge J, Jia Q, Liang C, Luo Y, Huang D, Sun A, et al,. (2005). Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells. Arterioscler Thromb Vasc Biol 25: 2157-2163.
45. Gharib SA, Nguyen EV, Lai Y, Plampin JD, Goodlett DR, Hallstrand TS, (2011). Induced sputum proteome in healthy subjects and asthmatic patients. J Allergy Clin Immunol 128: 1176-1184.e6.
46. Hacker S, Lambers C, Hoetzenecker K, Pollreisz A, Aigner C, Lichtenauer M, et al,. (2009). Elevated HSP27, HSP70 and HSP90 alpha in chronic obstructive pulmonary disease: markers for immune activation and tissue destruction. Clin Lab 55: 31-40.
47. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN, (2009). House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 15: 410-416.
48. Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, et al,. (2010). Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 42: 45-52.
49. He M, Kubo H, Morimoto K, Fujino N, Suzuki T, Takahasi T, et al,. (2011). Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep 12: 358-364.
50. Hilmenyuk T, Bellinghausen I, Heydenreich B, Ilchmann A, Toda M, Grabbe S, et al,. (2010). Effects of glycation of the model food allergen ovalbumin on antigen uptake and presentation by human dendritic cells. Immunology 129: 437-445.
51. Hirota T, Takahashi A, Kubo M, Tsunoda T, Tomita K, Doi S, et al,. (2011). Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet 43: 893-896.
52. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M, (2002). Multiple control of interleukin-8 gene expression. J Leukoc Biol 72: 847-855.
53. Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, et al,. (2002). RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 3: 123-135.
54. Hollingsworth JW II, Cook DN, Brass DM, Walker JKL, Morgan DL, Foster WM, et al,. (2004). The role of toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med 170: 126-132.
55. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, et al,. (1995). The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. J Biol Chem 270: 25752-25761.
56. Hou C, Zhao H, Li W, Liang Z, Zhang D, Liu L, et al,. (2011a). Increased heat shock protein 70 levels in induced sputum and plasma correlate with severity of asthma patients. Cell Stress Chaperones 16: 663-671.
57. Hou C, Zhao H, Liu L, Li W, Zhou X, Lv Y, et al,. (2011b). High mobility group protein B1 (HMGB1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med 17: 807-815.
58. Hou CC, Zhao HJ, Cai SX, Liu LY, Shen XB, Mo GW, (2010). Expression of high mobility group box-1 in the lung tissue and BALF of asthmatic mice and the influence of dexamethasone. Nan Fang Yi Ke Da Xue Xue Bao 30: 2051-2054.
59. Hudson BI, Carter AM, Harja E, Kalea AZ, Arriero M, Yang H, et al,. (2007). Identification, classification, and expression of RAGE gene splice variants. FASEB J 22: 1572-1580.
60. Hudson BI, Kalea AZ, del Mar Arriero M, Harja E, Boulanger E, D'Agati V, et al,. (2008). Interaction of the RAGE cytoplasmic domain with diaphanous-1 Is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem 283: 34457-34468.
61. Huttunen HJ, Kuja-Panula J, Rauvala H, (2002). Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation. J Biol Chem 277: 38635-38646.
62. Ishihara K, Tsutsumi K, Kawane S, Nakajima M, Kasaoka T, (2003). The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a d-domain-like docking site. FEBS Lett 550: 107-113.
63. Jang Y, Kim JY, Kang S-M, Kim J-S, Chae JS, Kim OY, et al,. (2007). Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 56: 199-205.
64. Jaradat M, Stapleton C, Tilley SL, Dixon D, Erikson CJ, McCaskill JG, et al,. (2006). Modulatory role for retinoid-related orphan receptor {alpha} in allergen-induced lung inflammation. Am J Respir Crit Care Med 174: 1299-1309.
65. Kalousová M, Hodková M, Kazderová M, Fialová J, Tesar V, Dusilová-Sulková S, et al,. (2006). Soluble receptor for advanced glycation end products in patients with decreased renal function. Am J Kidney Dis 47: 406-411.
66. Kamioka M, Ishibashi T, Ohkawara H, Nagai R, Sugimoto K, Uekita H, et al,. (2011). Involvement of membrane type 1-matrix metalloproteinase (MT1-MMP) in RAGE activation signaling pathways. J Cell Physiol 226: 1554-1563.
67. Kanazawa H, Tochino Y, Asai K, Ichimaru Y, Watanabe T, Hirata K, (2012). Validity of HMGB1 measurement in epithelial lining fluid in patients with COPD. Eur J Clin Invest 42: 419-426.
68. Kim OY, Jo SH, Jang Y, Chae JS, Kim JY, Hyun YJ, et al,. (2009). G allele at RAGE SNP82 is associated with proinflammatory markers in obese subjects. Nutr Res 29: 106-113.
69. Koch M, Chitayat S, Dattilo BM, Schiefner A, Diez J, Chazin WJ, et al,. (2010). Structural basis for ligand recognition and activation of RAGE. Structure 18: 1342-1352.
70. Kodavanti UP, Thomas R, Ledbetter AD, Schladweiler MC, Shannahan JH, Wallenborn JG, et al,. (2011). Vascular and cardiac impairments in rats inhaling ozone and diesel exhaust particles. Environ Health Perspect 119: 312-318.
71. Kumano-Kuramochi M, Ohnishi-Kameyama M, Xie Q, Niimi S, Kubota F, Komba S, et al,. (2009). Minimum stable structure of the receptor for advanced glycation end product possesses multi ligand binding ability. Biochem Biophys Res Commun 386: 130-134.
72. Lajoie S, Lewkowich IP, Suzuki Y, Clark JR, Sproles AA, Dienger K, et al,. (2010). Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol 11: 928-935.
73. Lambrecht BN, Hammad H, (2010). The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet 376: 835-843.
74. Lanati N, Emanuele E, Brondino N, Geroldi D, (2010). Soluble RAGE-modulating drugs: state-of-the-art and future perspectives for targeting vascular inflammation. Curr Vasc Pharmacol 8: 86-92.
75. Leclerc E, Fritz G, Weibel M, Heizmann CW, Galichet A, (2007). S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem 282: 31317-31331.
76. Leclerc E, Fritz G, Vetter SW, Heizmann CW, (2009). Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 1793: 993-1007.
77. Li G, Tang J, Du Y, Lee CA, Kern TS, (2011a). Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia. Mol Vis 17: 3156-3165.
78. Li K, Dai D, Zhao B, Yao L, Yao S, Wang B, et al,. (2010). Association between the RAGE G82S polymorphism and Alzheimer's disease. J Neural Transm 117: 97-104.
79. Li K, Zhao B, Dai D, Yao S, Liang W, Yao L, et al,. (2011b). A functional p.82G>S polymorphism in the RAGE gene is associated with multiple sclerosis in the Chinese population. Mult Scler 17: 914-921.
80. Liao W, Lin J-X, Leonard WJ, (2011). IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 23: 598-604.
81. Makam M, Diaz D, Laval J, Gernez Y, Conrad CK, Dunn CE, et al,. (2009). Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc Natl Acad Sci USA 106: 5779-5783.
82. Manfredi AA, Capobianco A, Esposito A, De Cobelli F, Canu T, Monno A, et al,. (2008). Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol 180: 2270-2275.
83. Merkel D, Rist W, Seither P, Weith A, Lenter MC, (2005). Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification. Proteomics 5: 2972-2980.
84. Messmer D, Yang H, Telusma G, Knoll F, Li J, Messmer B, et al,. (2004). High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 173: 307-313.
85. Miniati M, Monti S, Basta G, Cocci F, Fornai E, Bottai M, (2011). Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Respir Res 12: 37.
86. Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, Luisetti M, (2006). The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol 19: 1437-1445.
87. Moser B, Desai DD, Downie MP, Chen Y, Yan SF, Herold K, et al,. (2007). Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo. J Immunol 179: 8051-8058.
88. Mukherjee TK, Mukhopadhyay S, Hoidal JR, (2008). Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology. Respir Physiol Neurobiol 162: 210-215.
89. Myint K-M, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H, et al,. (2006). RAGE control of diabetic nephropathy in a mouse model. Diabetes 55: 2510-2522.
90. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, et al,. (1992). Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004.
91. Nin JWM, Jorsal A, Ferreira I, Schalkwijk CG, Prins MH, Parving H-H, et al,. (2010). Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes. Diabetes 59: 2027-2032.
92. Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, et al,. (2009). Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutr Metab Cardiovasc Dis 19: 129-134.
93. Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, Ihanus E, et al,. (2007). A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 26: 1129-1139.
94. Osawa M, Yamamoto Y, Munesue S, Murakami N, Sakurai S, Watanabe T, et al,. (2007). De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts. Biochim Biophys Acta 1770: 1468-1474.
95. Ostendorp T, Leclerc E, Galichet A, Koch M, Demling N, Weigle B, et al,. (2007). Structural and functional insights into RAGE activation by multimeric S100B. EMBO J 26: 3868-3878.
96. Ozseker F, Buyukozturk S, Depboylu B, Yilmazbayham D, Karayigit E, Gelincik A, et al,. (2006). Serum amyloid A in induced sputum of asthmatics: A new look to an old marker. Int Immunopharmacol 6: 1569-1576.
97. Park H, Adsit FG, Boyington JC, (2010). The 1.5 Ã crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding. J Biol Chem 285: 40762-40770.
98. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ, Chow WS, et al,. (1998). Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4: 1025-1031.
99. Park SJ, Kleffmann T, Hessian PA, (2011). The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparagine 81. J Biol Chem 286: 21384-21392.
100. Peden DB, (2011). The role of oxidative stress and innate immunity in O3 and endotoxin-induced human allergic airway disease. Immunol Rev 242: 91-105.
101. Peng WH, Lu L, Wang LJ, Yan XX, Chen QJ, Zhang Q, et al,. (2009). RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus. Arch Med Res 40: 393-398.
102. Phipps S, Lam CE, Kaiko GE, Foo SY, Collison A, Mattes J, et al,. (2009). Toll/IL-1 signaling is critical for house dust mite-specific Th1 and Th17 responses. Am J Respir Crit Care Med 179: 883-893.
103. Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A, (2005). Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 7: R817-R824.
104. Pullerits R, Brisslert M, Jonsson IM, Tarkowski A, (2006). Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1. Arthritis Rheum 54: 3898-3907.
105. Qin Y-H, Dai S-M, Tang G-S, Zhang J, Ren D, Wang Z-W, et al,. (2009). HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. J Immunol 183: 6244-6250.
106. Rao NV, Argyle B, Xu X, Reynolds PR, Walenga JM, Prechel M, et al,. (2010). Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands. Am J Physiol 299: C97-C110.
107. Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, et al,. (2008). A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 22: 3716-3727.
108. Ray R, Zhang Z, Lee Y-C, Gao J-L, Mukherjee AB, (2006). Uteroglobin suppresses allergen-induced TH2 differentiation by down-regulating the expression of serum amyloid A and SOCS-3 genes. FEBS Lett 580: 6022-6026.
109. Reddy MA, Li S-L, Sahar S, Kim Y-S, Xu Z-G, Lanting L, et al,. (2006). Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem 281: 13685-13693.
110. Repapi E, Sayers I, Wain LV, Burton PR, Johnson T, Obeidat ME, et al,. (2010). Genome-wide association study identifies five loci associated with lung function. Nat Genet 42: 36-44.
111. Reynolds PR, Kasteler SD, Cosio MG, Sturrock A, Huecksteadt T, Hoidal JR, (2008). RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 294: L1094-L1101.
112. Reynolds PR, Wasley KM, Allison CH, (2011a). Diesel particulate matter induces receptor for advanced glycation end-products (RAGE) expression in pulmonary epithelial cells, and rage signaling influences NF-κB-mediated inflammation. Environ Health Perspect 119: 332-336.
113. Reynolds PR, Kasteler SD, Schmitt RE, Hoidal JR, (2011b). Receptor for advanced glycation end-products signals through ras during tobacco smoke-induced pulmonary inflammation. Am J Respir Cell Mol Biol 45: 411-418.
114. Reynolds PR, Stogsdill JA, Stogsdill MP, Heimann NB, (2011c). Up-regulation of RAGE by alveolar epithelium influences cytodifferentiation and causes severe lung hypoplasia. Am J Respir Cell Mol Biol 45: 1195-1202.
115. Rouhiainen A, Kuja-Panula J, Wilkman E, Pakkanen J, Stenfors J, Tuominen RK, et al,. (2004). Regulation of monocyte migration by amphoterin (HMGB1). Blood 104: 1174-1182.
116. Ruan BH, Li X, Winkler AR, Cunningham KM, Kuai J, Greco RM, et al,. (2010). Complement C3a, CpG oligos, and DNA/C3a complex stimulate IFN-α production in a receptor for advanced glycation end product-dependent manner. J Immunol 185: 4213-4222.
117. Sakaguchi M, Murata H, Yamamoto KI, Ono T, Sakaguchi Y, Motoyama A, et al,. (2011). TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS ONE 6: e23132.
118. Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T, (2009). Inflammation in Alzheimer's disease: amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 87: 181-194.
119. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, et al,. (1992). Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267: 14987-14997.
120. Semba RD, Ferrucci L, Fink JC, Sun K, Beck J, Dalal M, et al,. (2009). Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women. Am J Kidney Dis 53: 51-58.
121. Shang G-H, Jia C-Q, Tian H, Xiao W, Li Y, Wang A-H, et al,. (2009). Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer. Respir Med 103: 1949-1953.
122. Shang L, Ananthakrishnan R, Li Q, Quadri N, Abdillahi M, Zhu Z, et al,. (2010). RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3β signaling pathways. PLoS ONE 5: e10092.
123. Shirasawa M, Fujiwara N, Hirabayashi S, Ohno H, Iida J, Makita K, et al,. (2004). Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 9: 165-174.
124. Simpson JL, Phipps S, Gibson PG, (2009). Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. Pharmacol Ther 124: 86-95.
125. Smith DJ, Yerkovich ST, Towers MA, Carroll ML, Thomas R, Upham JW, (2010). Reduced soluble receptor for advanced glycation end products in chronic obstructive pulmonary disease. Eur Respir J 37: 516-522.
126. Sukkar MB, Wood LG, Tooze M, Simpson JL, McDonald VM, Gibson PG, et al,. (2011). Soluble RAGE is deficient in neutrophilic asthma and chronic obstructive pulmonary disease. Eur Respir J 39: 721-729.
127. Sung H-J, Ahn J-M, Yoon Y-H, Rhim T-Y, Park C-S, Park J-Y, et al,. (2010). Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer. J Proteome Res 10: 1383-1395.
128. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H, (2000). The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 275: 25781-25790.
129. Thomas M, Söderlund J, Lehto M, Mäkinen VP, Moran J, Cooper M, et al,. (2011). Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia 54: 2669-2677.
130. Tian J, Avalos AM, Mao S-Y, Chen B, Senthil K, Wu H, et al,. (2007). Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8: 487-496.
131. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, et al,. (2009). Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 457: 585-588.
132. Upragarin N, Landman WJM, Gaastra W, Gruys E, (2005). Extrahepatic production of acute phase serum amyloid A. Histol Histopathol 20: 1295-1307.
133. Urieli-Shoval S, Cohen P, Eisenberg S, Matzner Y, (1998). Widespread expression of serum amyloid A in histologically normal human tissues: predominant localization to the epithelium. J Histochem Cytochem 46: 1377-1384.
134. Vazzana N, Santilli F, Cuccurullo C, Davà G, (2009). Soluble forms of RAGE in internal medicine. Intern Emerg Med 4: 389-401.
135. Vignola A, Chanez P, Polla B, Vic P, Godard P, Bousquet J, (1995). Increased expression of heat shock protein 70 on airway cells in asthma and chronic bronchitis. Am J Respir Cell Mol Biol 13: 683-691.
136. Vugmeyster Y, DeFranco D, Pittman DD, Xu X, (2010). Pharmacokinetics and lung distribution of a humanized anti-RAGE antibody in wild-type and RAGE-/- mice. Mabs 2: 571-575.
137. Wang Y, Wang H, Piper MG, McMaken S, Mo X, Opalek J, et al,. (2010). sRAGE induces human monocyte survival and differentiation. J Immunol 185: 1822-1835.
138. Wang YH, Wills-Karp M, (2011). The potential role of interleukin-17 in severe asthma. Curr Allergy Asthma Rep 11: 388-394.
139. Watanabe T, Asai K, Fujimoto H, Tanaka H, Kanazawa H, Hirata K, (2011). Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir Med 105: 519-525.
140. Williams AS, Leung S, Nath P, Khorasani NM, Bhavsar P, Issa R, et al,. (2007). Role of TLR2, TLR4, and MyD88 in murine ozone-induced airway hyperresponsiveness and neutrophilia. J Appl Physiol 103: 1189-1195.
141. Xie J, Reverdatto S, Frolov A, Hoffmann R, Burz DS, Shekhtman A, (2008). Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem 283: 27255-27269.
142. Xu D, Young J, Song D, Esko JD, (2011). heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE). J Biol Chem 286: 41736-41744.
143. Xu N-Y, Zhang S-P, Nie J-H, Li J-X, Tong J, (2008). Radon-induced proteomic profile of lung tissue in rats. J Toxicol Environ Health 71: 361-366.
144. Xu Y, Toure F, Qu W, Lin L, Song F, Shen X, et al,. (2010). Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages. J Biol Chem 285: 23233-23240.
145. Yamagishi S-I, Adachi H, Nakamura K, Matsui T, Jinnouchi Y, Takenaka K, et al,. (2006). Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects. Metabolism 55: 1227-1231.
146. Yamakawa N, Uchida T, Matthay MA, Makita K, (2011). Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells. Am J Physiol 300: L516-L525.
147. Yamamoto Y, Miura J, Sakurai S, Watanabe T, Yonekura H, Tamei H, et al,. (2007). Assaying soluble forms of receptor for advanced glycation end products. Arterioscler Thromb Vasc Biol 27: e33-e34.
148. Yamamoto Y, Harashima A, Saito H, Tsuneyama K, Munesue S, Motoyoshi S, et al,. (2011). Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J Immunol 186: 3248-3257.
149. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, et al,. (1996). RAGE and amyloid-[beta] peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.
150. Yan SD, Zhu H, Zhu A, Golabek A, Du H, Roher A, et al,. (2000). Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med 6: 643-651.
151. Yan SF, Ramasamy R, Schmidt AM, (2010). The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 106: 842-853.
152. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ, (2007a). High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 81: 59-66.
153. Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, et al,. (2010). A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 107: 11942-11947.
154. Yang Z, Yan WX, Cai H, Tedla N, Armishaw C, Di Girolamo N, et al,. (2007b). S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity. J Allergy Clin Immunol 119: 106-114.
155. Young RP, Hopkins R, Eaton TE, (2009). Pharmacological actions of statins: potential utility in COPD. Eur Respir Rev 18: 222-232.
156. Young RP, Hay BA, Hopkins RJ, (2011). Does RAGE protect smokers from COPD? Eur Respir J 38: 743-744.
157. Zen K, Chen CXJ, Chen Y-T, Wilton R, Liu Y, (2007). Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium. J Immunol 178: 2483-2490.
158. Zhang H, Tasaka S, Shiraishi Y, Fukunaga K, Yamada W, Seki H, et al,. (2008a). Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am J Respir Crit Care Med 178: 356-362.
159. Zhang L, Bukulin M, Kojro E, Roth A, Metz VV, Fahrenholz F, et al,. (2008b). Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J Biol Chem 283: 35507-35516.
160. Zhang S, Xu N, Nie J, Dong L, Li J, Tong J, (2008c). Proteomic alteration in lung tissue of rats exposed to cigarette smoke. Toxicol Lett 178: 191-196.
161. Zhang SP, Wu YW, Wu ZZ, Liu HY, Nie JH, Tong J, (2009). Up-regulation of RAGE and S100A6 in rats exposed to cigarette smoke. Environ Toxicol Pharmacol 28: 259-264.
162. Zhu XM, Yao YM, Liang HP, Xu S, Dong N, Yu Y, et al,. (2009). The effect of high mobility group box-1 protein on splenic dendritic cell maturation in rats. J Interferon Cytokine Res 29: 677-686.
163. van Zoelen MAD, Yang H, Florquin S, Meijers JCM, Akira S, Arnold B, et al,. (2009). Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 31: 280-284.
164. Zong H, Madden A, Ward M, Mooney MH, Elliott CT, Stitt AW, (2010). Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction. J Biol Chem 285: 23137-23146.